Distillate Capital Partners
Distillate Capital Partners reported 118 stocks worth $1.9B in its 13F filing for Q2 2026, filed Aug 14, 2026. Its largest holdings are MRK (2.5%), CRM (2.3%) and CMCSA (2.1%). Compared with Q1 2026, the fund opened new positions in ICE, CME and FDX, added to CRM, CMCSA and UBER, trimmed MRK, ABBV and CI and sold out of QCOM, PCAR and CTRA.
Holdings
| # | Stock | Value | Weight | Shares | Change | Shares, 8 qtrs | Held |
|---|---|---|---|---|---|---|---|
| 1 | ![]() MRK Merck & Co Inc | $48.5M | 2.5% | 377K | −70K (−16%) | 6 of 8 | |
| 2 | ![]() CRM Salesforce Inc | $43.5M | 2.3% | 278K | +63K (+29%) | 6 of 8 | |
| 3 | ![]() CMCSA Comcast Corp New | $40.8M | 2.1% | 1.7M | +482K (+40%) | 8 of 8 | |
| 4 | ![]() ABBV Abbvie Inc | $38.9M | 2.0% | 155K | −106K (−41%) | 8 of 8 | |
| 5 | ![]() UBER Uber Technologies Inc | $34.8M | 1.8% | 482K | +5,442 (+1%) | 5 of 8 | |
| 6 | ![]() ACN Accenture PLC Ireland | $34.7M | 1.8% | 279K | +121K (+77%) | 4 of 8 | |
| 7 | ![]() BKNG Booking Hldgs Inc | $30.4M | 1.6% | 171K | +163K (+2021%) | 8 of 8 | |
| 8 | ![]() CI The Cigna Group | $29M | 1.5% | 105K | −1,873 (−2%) | 8 of 8 | |
| 9 | ![]() MO Altria Group Inc | $28.9M | 1.5% | 402K | −9,625 (−2%) | 8 of 8 | |
| 10 | ![]() MPC Marathon Petroleum | $28.3M | 1.5% | 111K | −4,020 (−4%) | 6 of 8 |
Positions at Jun 30, 2026, as reported. Change is against the fund's Q1 2026 filing; weight is the share of the fund's reported stocks.
Sold out
held in Q1 2026, gone in Q2 2026| Stock | Value last quarter | Shares sold |
|---|---|---|
![]() QCOM Qualcomm Inc | $32.7M | 254K |
![]() PCAR Paccar Inc | $20.5M | 178K |
![]() CTRA Coterra Energy Inc | $20.1M | 572K |
![]() EME Emcor Group Inc | $18.9M | 26K |
![]() STZ Constellation Brands Incclass Class A | $18.4M | 123K |
🔒 Free account: see all 27.
Reported value
last 8 quartersThe value of the US stocks the fund reported, at quarter end prices. It moves with the market as well as with buying and selling.
Filings for Q2 2026
straight from the SEC| Filed | Form | Quarter | |
|---|---|---|---|
| Aug 14, 2026 | 13F-HR | Q2 2026 | SEC filing ↗ |
Other superinvestors
All hedge fund holdings →Distillate Capital Partners 13F FAQ
What does Distillate Capital Partners own?
Distillate Capital Partners reported 118 stocks worth $1.9B in its 13F filing for Q2 2026, filed Aug 14, 2026. Its largest holdings are MRK (2.5%), CRM (2.3%) and CMCSA (2.1%). The table above lists every position in the filing (the top 10 without an account).
What did Distillate Capital Partners buy and sell in Q2 2026?
Compared with Q1 2026: 27 new positions, 47 added to, 41 trimmed and 27 sold out. New positions include ICE, CME and FDX. It sold all of QCOM, PCAR and CTRA.
When will Distillate Capital Partners file its next 13F?
Holdings as of Sep 30, 2026 are due by Nov 16, 2026. The filing appears on this page within minutes of reaching the SEC.
How much is Distillate Capital Partners's portfolio worth?
The Q2 2026 filing reports $1.9B in US stocks. That leaves out cash, bonds, short positions and most foreign holdings, so the fund's total assets are usually larger.
For informational and educational purposes only. Not investment advice, and not a recommendation to buy or sell any security. Holdings come from the fund's SEC Form 13F filings as reported and show positions at the end of the quarter, up to 45 days before the filing. The fund may have changed its positions since. A 13F leaves out short positions, cash, bonds and most foreign holdings. See all hedge fund holdings.














